GRI Bio, Inc.
GRINasdaqCIK 1824293HealthcareFiscal year ends Dec 31
Reports and events: 156 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2816:43 ET | DEF 14A | Proxy statementPeriod 2026-11-04 | 0001824293-26-000060 |
| 2026-09-0808:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000057 |
| 2026-08-1407:44 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001824293-26-000055 |
| 2026-06-1816:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000050 |
| 2026-05-1408:36 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000046 |
| 2026-05-1316:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001824293-26-000044 |
| 2026-02-0408:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-26-000040 |
| 2026-01-3007:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001824293-26-000033 |
| 2026-01-3020:22 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001824293-26-000030 |
| 2026-01-2808:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000017 |
| 2026-01-2116:10 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000014 |
| 2026-01-1608:00 ET | 8-K | 3.01 Delisting notice | 0001824293-26-000011 |
| 2026-01-1510:15 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001824293-26-000009 |
| 2026-01-0908:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000006 |
| 2026-01-0808:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-26-000002 |
| 2025-12-2908:08 ET | DEF 14A | Proxy statementPeriod 2026-01-15 | 0001824293-25-000173 |
| 2025-12-1216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-056751 |
| 2025-12-1208:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-056659 |
| 2025-12-1016:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000167 |
| 2025-12-1021:11 ET | S-1/A | Registration statement, amended | 0001628280-25-056215 |
| 2025-12-0808:19 ET | S-1 | Registration statement | 0001628280-25-055716 |
| 2025-12-0808:00 ET | 8-K | 8.01 Other events | 0001824293-25-000160 |
| 2025-12-0208:00 ET | 8-K | 3.01 Delisting notice | 0001824293-25-000155 |
| 2025-11-1407:45 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001824293-25-000151 |
| 2025-08-2009:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001824293-25-000126 |
| 2025-08-1406:57 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001824293-25-000106 |
| 2025-08-1316:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001824293-25-000096 |
| 2025-07-3109:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000094 |
| 2025-07-1116:17 ET | DEF 14A | Proxy statementPeriod 2025-08-13 | 0001824293-25-000089 |
| 2025-06-2608:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001824293-25-000082 |
| 2025-05-2307:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000079 |
| 2025-05-1508:38 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001824293-25-000073 |
| 2025-05-1508:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-25-000072 |
| 2025-05-0507:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000063 |
| 2025-04-1618:14 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001824293-25-000058 |
| 2025-04-0208:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-016066 |
| 2025-03-2615:11 ET | S-1/A | Registration statement, amended | 0001628280-25-014928 |
| 2025-03-2506:21 ET | S-1 | Registration statement | 0001628280-25-014582 |
| 2025-03-1708:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-25-000053 |
| 2025-03-1417:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001824293-25-000050 |
| 2025-03-1108:37 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000045 |
| 2025-02-1916:08 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-25-000042 |
| 2025-02-1116:05 ET | 8-K | 5.07 Shareholder vote results | 0001824293-25-000039 |
| 2025-01-1716:05 ET | DEF 14A | Proxy statementPeriod 2025-02-11 | 0001824293-25-000011 |
| 2024-12-2016:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-24-000159 |
| 2024-11-1416:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001824293-24-000153 |
| 2024-11-1416:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001824293-24-000151 |
| 2024-10-2408:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-24-000143 |
| 2024-10-2216:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001824293-24-000141 |
| 2024-09-1116:36 ET | 8-K/A | 3.01 Delisting notice | 0001824293-24-000138 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.